Anderson Raymond

Insider profile

Performance

Overall performance
3.3

Performance over holding periods
4.2
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 96% 68% 82%
Transactions
5 80% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return 121%
Success rate 73%
Average holding period 220
Transactions 28
Anderson Raymond's trades of Monopar Therapeutics Inc.'s stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
0.43
Quantity 40,123
Value £17,253
Transaction date
Purchase
Price
1.04
Quantity 30,372
Value £31,572
Transaction date
Sale
Price
2.32
Quantity 600,000
Value £1,389,000
Transaction date
Purchase
Price
1.12
Quantity 15,000
Value £16,800
Transaction date
Purchase
Price
0.80
Quantity 20,909
Value £16,727
Transaction date
Purchase
Price
1.80
Quantity 5,556
Value £10,001
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-27 2026-08-25 PlS Planned sale
59,054 +21.3%
295.46
US$4,481,247
59,054 +21.3% 295.46 US$4,481,247
2026-08-27 2026-08-25 PlS Planned sale
17,324 +12.3%
385.56
US$4,825,717
17,324 +12.3% 385.56 US$4,825,717
2026-08-27 2026-08-25 PlS Planned sale
84,918 -15.5%
60.17
US$4,710,026
84,918 -15.5% 60.17 US$4,710,026
2026-08-25 2026-08-25 PrS Proposed sale
6,284
111.36
US$699,786
6,284 111.36 US$699,786
2026-02-11 2026-02-09 S Sale
40,123
0.43
£17,253
40,123 0.43 £17,253
2024-01-29 2024-01-26 B Purchase
30,372
1.04
£31,572
30,372 1.04 £31,572
2023-02-17 2023-02-16 S Sale
600,000
2.32
£1,389,000
600,000 2.32 £1,389,000
2020-01-06 2020-01-06 B Purchase
15,000
1.12
£16,800
15,000 1.12 £16,800
2019-06-24 2019-06-24 B Purchase
20,909
0.80
£16,727
20,909 0.80 £16,727
2018-01-24 2018-01-24 B Purchase
5,556
1.80
£10,001
5,556 1.80 £10,001